MonseÑeros, Rachem .

HRN: 23-73-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
CEFUROXIME 750MG (VIAL)
08/20/2025
08/27/2025
IV
750mg
Q8
TC SEPSIS
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines